Trial Information

Summary: Seeking Participants with a Diagnosis of Autism Spectrum Disorder

Research at Beth Israel Deaconess Medical Center is investigating whether non-invasive repetitive transcranial magnetic stimulation can improve language skills in individuals with autism spectrum disorders.

• Transcranial magnetic stimulation (TMS) is an experimental way to transiently activate specific brain areas through the scalp that has been used for the past 20 years in neurology and psychiatry. Safety guidelines have been developed that will be closely followed. Past experience has documented efficacy of repetitive TMS in patients with language problems due to various diseases.
• Study involves up to 6 visits.
• Subjects will be asked to undergo a neurological exam, neuropsychological assessments, language assessment, MRI, and TMS.
• Study Eligibility: Subjects must be 18-65 years of age, diagnosed with autism spectrum disorders, have no history known genetic disorder (e.g., NF1, tuberous sclerosis), cerebral palsy, frank neurological damage, or significant dysmorphology.
• Subjects will be compensated $60 per visit for their participation.

If you are interested, or to learn more, please contact Shirley at 617-667-5229 or sfecteau@bidmc.harvard.edu

If you would like to learn more about participating in this study, please send an e-mail message using the form below.